Department of Radiology, University of Iowa, Iowa City, Iowa;
Radiology Associates of North Texas, Fort Worth, Texas.
J Nucl Med. 2021 Dec;62(Suppl 3):48S-59S. doi: 10.2967/jnumed.121.262752.
Interest in performing dosimetry for clinical radiopharmaceutical therapy procedures has grown in recent years. Several approved therapies include dosimetry in the Food and Drug Administration-approved label instructions, and other therapies are best used under a patient-tailored paradigm. This paper, which is a product of the Society of Nuclear Medicine and Molecular Imaging Dosimetry Task Force, presents motivations and general workflows for radiopharmaceutical therapy dosimetry, as well as existing strategies for obtaining reimbursement for clinical activities related to dosimetry. Several specific patient examples are provided, including suggested codes for reimbursement. In addition to current reimbursement approaches, key dosimetry services that are not supported under the current coding structure are presented and suggested as areas of focus in the coming years.
近年来，人们对临床放射性药物治疗程序进行剂量学研究的兴趣日益浓厚。一些已批准的治疗方法包括在食品和药物管理局批准的标签说明中进行剂量学，而其他治疗方法最好根据患者的具体情况进行。本文是核医学与分子成像剂量学工作组的成果，介绍了放射性药物治疗剂量学的动机和一般工作流程，以及获得与剂量学相关的临床活动报销的现有策略。本文还提供了几个具体的患者示例，包括建议的报销代码。除了当前的报销方法外，本文还提出了当前编码结构不支持的关键剂量学服务，并建议将其作为未来几年的重点关注领域。
